Your browser doesn't support javascript.
loading
Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
Bi, Yanghui; Guo, Shixing; Xu, Xiaoqin; Kong, Pengzhou; Cui, Heyang; Yan, Ting; Ma, Yanchun; Cheng, Yikun; Chen, Yunqing; Liu, Xue; Zhang, Ling; Cheng, Caixia; Xu, Enwei; Qian, Yu; Yang, Jian; Song, Bin; Li, Hongyi; Wang, Fang; Hu, Xiaoling; Liu, Xiangchen; Niu, Xia; Zhai, Yuanfang; Liu, Jing; Li, Yaoping; Cheng, Xiaolong; Cui, Yongping.
Afiliação
  • Bi Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Guo S; Shenzhen Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Peking University Shenzhen Hospital, Shenzhen, 518035, P.R. China.
  • Xu X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Kong P; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Cui H; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Yan T; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Ma Y; Shenzhen Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Peking University Shenzhen Hospital, Shenzhen, 518035, P.R. China.
  • Cheng Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Chen Y; Shenzhen Peking University-Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Peking University Shenzhen Hospital, Shenzhen, 518035, P.R. China.
  • Liu X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Zhang L; College of Letter & Science, University of California Berkeley, Berkeley, California, 94704, USA.
  • Cheng C; Surgery Special Wards, Shanxi Cancer Hospital, Taiyuan, Shanxi, 030001, P.R. China.
  • Xu E; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Qian Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Yang J; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Song B; Department of Pathology, the First Hospital, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Li H; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Wang F; Department of Pathology, Shanxi Cancer Hospital, Taiyuan, Shanxi, 030001, P.R. China.
  • Hu X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Liu X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Niu X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Zhai Y; Department of Oncology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Liu J; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Li Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Cheng X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
  • Cui Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, 030001, P.R. China.
Cell Death Dis ; 11(4): 296, 2020 04 27.
Article em En | MEDLINE | ID: mdl-32341351
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Biomarcadores Tumorais / Fatores de Transcrição Forkhead / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Cell Death Dis Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Biomarcadores Tumorais / Fatores de Transcrição Forkhead / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Cell Death Dis Ano de publicação: 2020 Tipo de documento: Article